期刊
NATURE BIOTECHNOLOGY
卷 28, 期 11, 页码 1165-1171出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nbt1110-1165
关键词
-
Last year, the biologics sector managed single-digit growth in the United States, driven mainly by products indicated for oncology, diabetes and autoimmune disorders. Lurking on the horizon, though, are challenges, such as pricing, competition and follow-on molecules.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据